JPRN-jRCTs051180224已完成未知
The efficacy and safety of photodynamic therapy for central serous chorioretinopathy - Photodynamic therapy for central serous chorioretinopathy
Sotozono Chie0 个研究点目标入组 8 人开始时间: 2019年3月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
8 eyes were enrolled in this study. PDT for CSC seemed to be a short-term efficacy and safety profile in this study. Because this study was unexpectedly conducted in a small number of cases, we are unable to conclude the efficacy and safety of PDT for CSC.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30age 至 100age（—）
- 性别
- All
入选标准
- •1.3 months or more after onset
- •2.presence of active angiographic leakage under or adjacent to fovea
- •in fluorescein angiography
- •3.presence of serous retinal detachment on optical coherence tomography
- •4.written informed consent
排除标准
- •1. drug allery to verteporfin
- •2. pregnant or expecting pregnancy
- •3. porphyria
- •4. macular diseases other than central serous chorioretinopathy
- •5. others (inappropriate case judged by investigator or subinvestigators)
研究者
相似试验
Unknown
4 期
Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous ChorioretinopathyChronic Central Serous ChorioretinopathyNCT03079141Leiden University Medical Center107
招募中
2 期
Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe AcnePhotodynamic TherapyAcneNCT06311890Xiyuan Hospital of China Academy of Chinese Medical Sciences46
已完成
不适用
Efficacy and Safety of Photodynamic Therapy for Unresectable CholangiocarcinomaCholangiocarcinomaNCT02585856First People's Hospital of Hangzhou39
进行中（未招募）
3 期
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).Superficial Basal Cell CarcinomaNCT03573401Biofrontera Inc.187
尚未招募
不适用
A Comparative Study of Endoscopic Submucosal Dissection and Photodynamic Therapy for Early Esophageal CancerEsophageal Carcinoma in Situ AJCC V7NCT05208775The First Affiliated Hospital of Henan University of Science and Technology46